Medic Spahic and colleagues identified growth hormone (GH) and myoglobin (MB) as specific biomarkers for POTS, with POTS patients showing higher plasma levels of GH (especially in women) and lower levels of MB (particularly in men) compared to controls [85]. This evidence concerns the gene GH1 and postural orthostatic tachycardia syndrome.